These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Use of compartmental analysis to describe effects of dietary fat saturation and load on plasma triglyceride dynamics in the rat. Green MH; Faulkner PL; Green JB Prog Food Nutr Sci; 1988; 12(3):255-78. PubMed ID: 3252344 [TBL] [Abstract][Full Text] [Related]
23. Pathophysiology of triglyceride-rich particles. A. Metabolism of triglyceride-rich particles. Shepherd J; Krauss RM Am J Cardiol; 1991 Jul; 68(3):5A-7A. PubMed ID: 1853852 [No Abstract] [Full Text] [Related]
25. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. Brunzell JD; Hazzard WR; Porte D; Bierman EL J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459 [TBL] [Abstract][Full Text] [Related]
26. [Pathophysiology of lipid transport in plasma]. Patsch JR Wien Med Wochenschr Suppl; 1989; 105():3-7. PubMed ID: 2694629 [TBL] [Abstract][Full Text] [Related]
27. [Role of the enterohepatic circulation of endogenous lipids in food lipid absorption]. Gal'perin IuM; Alimova EK; Astvatsatur'ian AT; Mikhas' NK; Baklykova NM Fiziol Zh SSSR Im I M Sechenova; 1982 Jan; 68(1):100-6. PubMed ID: 7060796 [TBL] [Abstract][Full Text] [Related]
28. Development and physiological regulation of intestinal lipid absorption. II. Dietary lipid absorption, complex lipid synthesis, and the intracellular packaging and secretion of chylomicrons. Mansbach CM; Gorelick F Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G645-50. PubMed ID: 17627968 [TBL] [Abstract][Full Text] [Related]
29. The type of dietary fat alters the hepatic uptake and biliary excretion of cholesterol from chylomicron remnants. Lambert MS; Avella MA; Botham KM; Mayes PA Br J Nutr; 2000 Apr; 83(4):431-8. PubMed ID: 10858701 [TBL] [Abstract][Full Text] [Related]
30. Determinants in the control of lipid transport and metabolism. Kayden HJ J Environ Pathol Toxicol; 1980 Mar; 3(4 Spec No):315-21. PubMed ID: 6771357 [No Abstract] [Full Text] [Related]
35. Recent insights into factors affecting remnant lipoprotein uptake. Williams KJ; Chen K Curr Opin Lipidol; 2010 Jun; 21(3):218-28. PubMed ID: 20463470 [TBL] [Abstract][Full Text] [Related]
36. Dietary Lipids and Insulin Action. Proceedings of the 2nd International Smolenice Insulin Symposium. Slovak Republic, September 12-16, 1992. Ann N Y Acad Sci; 1993 Jun; 683():1-388. PubMed ID: 8102514 [No Abstract] [Full Text] [Related]
37. Proceedings of the 3rd International Smolenice Insulin Symposium on Lipids and Syndromes of Insulin Resistance: From Molecular Biology to Clinical Medicine. Slovak Republic, August 28-September 1, 1996. Ann N Y Acad Sci; 1997 Sep; 827():1-582. PubMed ID: 9382461 [No Abstract] [Full Text] [Related]
38. Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk. Glavinovic T; Thanassoulis G; de Graaf J; Couture P; Hegele RA; Sniderman AD J Am Heart Assoc; 2022 Oct; 11(20):e025858. PubMed ID: 36216435 [TBL] [Abstract][Full Text] [Related]
40. Association Between Increased Lipid Profiles and Risk of Diabetic Retinopathy in a Population-Based Case-Control Study. Liu Z; Shao M; Ren J; Qiu Y; Li S; Cao W J Inflamm Res; 2022; 15():3433-3446. PubMed ID: 35711238 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]